Recently, a scFv against EGFR was developed and conjugated with Fe3O4/Au nanoparticles to create a bioprobe of a specific molecular magnetic resonance (scFv-Fe3O4/Au) to better identify EGFR-positive non-small cell lung cancer (NSCLC). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.